Asian Pacific Society of Respirology (APSR) 21st Congress 2016
Bangkok, Thailand, 12 – 15 November


Effectiveness of once-daily indacaterol/glycopyrronium (IND/GLY) with other combinations of inhaled maintenance therapies for COPD: the LUMIERE study design

Price D, Mezzi K, Roche N, Decuypere L, Molimard M, et al.
Respirology 2016; 21(Suppl 3): 188. Abstract ID – APSR6-0522.
[Full Text]

Real-life effects of switching LABA/ICS dry powder inhalers to formoterol/fluticasone in Korean asthma patients: the TRANSFFORM study

Price D, Park HS, Yoon D, Lee HY, Wan Yau Ming S, et al.
Respirology 2016; 21(Suppl 3): 22. Abstract ID – APSR6-0791.
[Full Text]

Real-life characteristics of asthma inhaler device use in South Korea

Wan Yau Ming S, Rhee CK, Park HY, Yoo KH, Kim DK, et al.
Respirology 2016; 21(Suppl 3): 170. Abstract ID – APSR6-0779.
[Full Text]


David Price, Jadwiga Wedzicha and Chin Kook Rhee discussing #FLAME #COPD #Ultibro #Breezhaler @APSRapsr

Prof David Price discussing groundbreaking new data on #COPD and #asthma at #APSR2016 @RespirologyAPSR

Omar Usmani, David Price and #mundipharma Chris Chen on inhaler app technology @APSRapsr: Improve technique, adherence and patient outcomes!